Arteriosclerosis, Thrombosis, and Vascular Biology. 1994;14:1648-1656
Arteriosclerosis and Thrombosis, Vol 14, 1648-1656, Copyright © 1994 by American Heart Association
ARTICLES |
Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques
ER O'Brien, MR Garvin, DK Stewart, T Hinohara, JB Simpson, SM Schwartz and CM Giachelli
Department of Pathology, University of Washington School of Medicine, Seattle.
How an atherosclerotic plaque evolves from minimal diffuse intimal hyperplasia to a critical lesion is not well understood. Cellular proliferation is a relatively infrequent and modest event in both primary and restenotic coronary atherectomy specimens, leading us to believe that other processes, such as the formation of extracellular matrix, cell migration, neovascularization, and calcification might be more important for lesion formation. The investigation of proteins that are overexpressed in plaque compared with the normal vessel wall may provide clues that will help determine which of these processes are key to lesion pathogenesis. One such molecule, osteopontin (OPN), is an arginine-glycine-aspartate-containing acidic phosphoprotein recently shown to be a novel component of human atherosclerotic plaques and selectively expressed in the rat neointima following balloon angioplasty. Using in situ hybridization and immunohistochemical methods, we demonstrate that in addition to macrophages, smooth muscle and endothelial cells synthesize OPN mRNA and protein in human coronary atherosclerotic plaque specimens obtained by directional atherectomy. In contrast, OPN mRNA and protein were not detected in nondiseased vessel walls. Furthermore, extracellular OPN protein collocalized with sites of early calcification in the plaque that were identified with a sensitive modification of the von Kossa staining technique. These findings, combined with studies showing that OPN has adhesive, chemotactic, and calcium-binding properties, suggest that OPN may contribute to cellular accumulations and dystrophic calcification in atherosclerotic plaques.
This article has been cited by other articles:
 |
|
 |
|
  M. Mizobuchi, D. Towler, and E. Slatopolsky Vascular Calcification: The Killer of Patients with Chronic Kidney Disease J. Am. Soc. Nephrol., July 1, 2009; 20(7): 1453 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Szalay, M. Sauter, M. Haberland, U. Zuegel, A. Steinmeyer, R. Kandolf, and K. Klingel Osteopontin: A Fibrosis-Related Marker Molecule in Cardiac Remodeling of Enterovirus Myocarditis in the Susceptible Host Circ. Res., April 10, 2009; 104(7): 851 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Duvall, D. Weiss, S. T. Robinson, F. M.F. Alameddine, R. E. Guldberg, and W. R. Taylor The Role of Osteopontin in Recovery from Hind Limb Ischemia Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 290 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Scatena, L. Liaw, and C. M. Giachelli Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease Arterioscler Thromb Vasc Biol, November 1, 2007; 27(11): 2302 - 2309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Leali, E. Moroni, F. Bussolino, and M. Presta Osteopontin Overexpression Inhibits in Vitro Re-endothelialization via Integrin Engagement J. Biol. Chem., July 6, 2007; 282(27): 19676 - 19684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. T. Gerthoffer Mechanisms of Vascular Smooth Muscle Cell Migration Circ. Res., March 16, 2007; 100(5): 607 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Minoretti, C. Falcone, M. Calcagnino, E. Emanuele, M. P. Buzzi, E. Coen, and D. Geroldi Prognostic significance of plasma osteopontin levels in patients with chronic stable angina Eur. Heart J., April 1, 2006; 27(7): 802 - 807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kato, Y. Momiyama, R. Ohmori, N. Tanaka, H. Taniguchi, K. Arakawa, M. Kusuhara, H. Nakamura, and F. Ohsuzu High Plasma Levels of Osteopontin in Patients With Restenosis After Percutaneous Coronary Intervention Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): e1 - e2. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Fuster, P. R. Moreno, Z. A. Fayad, R. Corti, and J. J. Badimon Atherothrombosis and High-Risk Plaque: Part I: Evolving Concepts J. Am. Coll. Cardiol., September 20, 2005; 46(6): 937 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Seipelt, C. L. Backer, C. Mavroudis, V. Stellmach, M. Cornwell, I. M. Seipelt, F. A. Schoendube, and S. E. Crawford Local delivery of osteopontin attenuates vascular remodeling by altering matrix metalloproteinase-2 in a rabbit model of aortic injury J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 355 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rattazzi, B. J. Bennett, F. Bea, E. A. Kirk, J. L. Ricks, M. Speer, S. M. Schwartz, C. M. Giachelli, and M. E. Rosenfeld Calcification of Advanced Atherosclerotic Lesions in the Innominate Arteries of ApoE-Deficient Mice: Potential Role of Chondrocyte-Like Cells Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1420 - 1425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Stier, Y. Ko, R. Forkert, C. Lutz, T. Neuhaus, E. Grunewald, T. Cheng, D. Dombkowski, L. M. Calvi, S. R. Rittling, et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size J. Exp. Med., June 6, 2005; 201(11): 1781 - 1791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Giachelli, M. Y. Speer, X. Li, R. M. Rajachar, and H. Yang Regulation of Vascular Calcification: Roles of Phosphate and Osteopontin Circ. Res., April 15, 2005; 96(7): 717 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Seipelt, C. L. Backer, C. Mavroudis, V. Stellmach, M. Cornwell, I. M. Seipelt, F. A. Schoendube, and S. E. Crawford Osteopontin expression and adventitial angiogenesis induced by local vascular endothelial growth factor 165 reduces experimental aortic calcification J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 773 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Graf and P. Stawowy Osteopontin: A Protective Mediator of Cardiac Fibrosis? Hypertension, December 1, 2004; 44(6): 809 - 810. [Full Text] [PDF]
|
|
|
|
 |
|
 M. W.M. Schellings, Y. M. Pinto, and S. Heymans Matricellular proteins in the heart: possible role during stress and remodeling Cardiovasc Res, October 1, 2004; 64(1): 24 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Abedin, Y. Tintut, and L. L. Demer Vascular Calcification: Mechanisms and Clinical Ramifications Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1161 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Koopmann, N. S. Fedarko, A. Jain, A. Maitra, C. Iacobuzio-Donahue, A. Rahman, R. H. Hruban, C. J. Yeo, and M. Goggins Evaluation of Osteopontin as Biomarker for Pancreatic Adenocarcinoma Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 487 - 491. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. R. Archacki, G. Angheloiu, X.-L. Tian, F. L. Tan, N. DiPaola, G.-Q. Shen, C. Moravec, S. Ellis, E. J. Topol, and Q. Wang Identification of new genes differentially expressed in coronary artery disease by expression profiling Physiol Genomics, September 29, 2003; 15(1): 65 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hao, G. Gabbiani, and M.-L. Bochaton-Piallat Arterial Smooth Muscle Cell Heterogeneity: Implications for Atherosclerosis and Restenosis Development Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1510 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Leali, P. Dell'Era, H. Stabile, B. Sennino, A. F. Chambers, A. Naldini, S. Sozzani, B. Nico, D. Ribatti, and M. Presta Osteopontin (Eta-1) and Fibroblast Growth Factor-2 Cross-Talk in Angiogenesis J. Immunol., July 15, 2003; 171(2): 1085 - 1093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Wesson, R. J. Johnson, M. Mazzali, A. M. Beshensky, S. Stietz, C. Giachelli, L. Liaw, C. E. Alpers, W. G. Couser, J. G. Kleinman, et al. Osteopontin Is a Critical Inhibitor of Calcium Oxalate Crystal Formation and Retention in Renal Tubules J. Am. Soc. Nephrol., January 1, 2003; 14(1): 139 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bidder, J.-S. Shao, N. Charlton-Kachigian, A. P. Loewy, C. F. Semenkovich, and D. A. Towler Osteopontin Transcription in Aortic Vascular Smooth Muscle Cells Is Controlled by Glucose-regulated Upstream Stimulatory Factor and Activator Protein-1 Activities J. Biol. Chem., November 8, 2002; 277(46): 44485 - 44496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Y. Speer, M. D. McKee, R. E. Guldberg, L. Liaw, H.-Y. Yang, E. Tung, G. Karsenty, and C. M. Giachelli Inactivation of the Osteopontin Gene Enhances Vascular Calcification of Matrix Gla Protein-deficient Mice: Evidence for Osteopontin as an Inducible Inhibitor of Vascular Calcification In Vivo J. Exp. Med., October 21, 2002; 196(8): 1047 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Li, S. Oparil, S. S. Kelpke, Y.-F. Chen, and J. A. Thompson Fibroblast Growth Factor Receptor-1 Signaling Induces Osteopontin Expression and Vascular Smooth Muscle Cell-Dependent Adventitial Fibroblast Migration In Vitro Circulation, August 13, 2002; 106(7): 854 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mohler III Vascular calcification: good, bad or ugly? Vascular Medicine, August 1, 2002; 7(3): 161 - 162. [PDF]
|
|
|
|
 |
|
 L. L Demer Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids Int. J. Epidemiol., August 1, 2002; 31(4): 737 - 741. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lehto, L. Niskanen, M. Suhonen, T. Ronnemaa, P. Saikku, and M. Laakso Association Between Chlamydia pneumoniae Antibodies and Intimal Calcification in Femoral Arteries of Nondiabetic Patients Arch Intern Med, March 11, 2002; 162(5): 594 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mazzali, T. Kipari, V. Ophascharoensuk, J.A. Wesson, R. Johnson, and J. Hughes Osteopontin--a molecule for all seasons QJM, January 1, 2002; 95(1): 3 - 13. [Full Text] [PDF]
|
|
|
|
|
|
G. K. Hansson Immune Mechanisms in Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1876 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Moiseeva Adhesion receptors of vascular smooth muscle cells and their functions Cardiovasc Res, December 1, 2001; 52(3): 372 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Hunt, G. W. Evans, A. R. Folsom, A. R. Sharrett, L. E. Chambless, C. H. Tegeler, and G. Heiss Acoustic Shadowing on B-Mode Ultrasound of the Carotid Artery Predicts Ischemic Stroke : The Atherosclerosis Risk in Communities (ARIC) Study Stroke, May 1, 2001; 32(5): 1120 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-P. Gadeau, H. Chaulet, D. Daret, M. Kockx, J.-M. Daniel-Lamazière, and C. Desgranges Time Course of Osteopontin, Osteocalcin, and Osteonectin Accumulation and Calcification After Acute Vessel Wall Injury J. Histochem. Cytochem., January 1, 2001; 49(1): 79 - 86. [Abstract] [Full Text]
|
|
|
|
|
|
S. Jono, M. D. McKee, C. E. Murry, A. Shioi, Y. Nishizawa, K. Mori, H. Morii, and C. M. Giachelli Phosphate Regulation of Vascular Smooth Muscle Cell Calcification Circ. Res., September 29, 2000; 87 (7): e10 - e17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yokosaki, N. Matsuura, T. Sasaki, I. Murakami, H. Schneider, S. Higashiyama, Y. Saitoh, M. Yamakido, Y. Taooka, and D. Sheppard The Integrin alpha 9beta 1 Binds to a Novel Recognition Sequence (SVVYGLR) in the Thrombin-cleaved Amino-terminal Fragment of Osteopontin J. Biol. Chem., December 17, 1999; 274(51): 36328 - 36334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Adams, J. M. Lemire, and S. M. Schwartz A Systematic Analysis of 40 Random Genes in Cultured Vascular Smooth Muscle Subtypes Reveals a Heterogeneity of Gene Expression and Identifies the Tight Junction Gene Zonula Occludens 2 as a Marker of Epithelioid "Pup" Smooth Muscle Cells and a Participant in Carotid Neointimal Formation Arterioscler Thromb Vasc Biol, November 1, 1999; 19(11): 2600 - 2608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bini, K. G. Mann, B. J. Kudryk, and F. J. Schoen Noncollagenous Bone Matrix Proteins, Calcification, and Thrombosis in Carotid Artery Atherosclerosis Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1852 - 1861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. WEITKAMP, P. CULLEN, G. PLENZ, H. ROBENEK, and J. RAUTERBERG Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque FASEB J, August 1, 1999; 13(11): 1445 - 1457. [Abstract] [Full Text]
|
|
|
|
|
|
L. R. Bonin, K. Madden, K. Shera, J. Ihle, C. Matthews, S. Aziz, N. Perez-Reyes, J. K. McDougall, and S. C. Conroy Generation and Characterization of Human Smooth Muscle Cell Lines Derived From Atherosclerotic Plaque Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 575 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Giachelli Ectopic Calcification : Gathering Hard Facts about Soft Tissue Mineralization Am. J. Pathol., March 1, 1999; 154(3): 671 - 675. [Full Text] [PDF]
|
|
|
|
|
|
T. Wada, M. D. McKee, S. Steitz, and C. M. Giachelli Calcification of Vascular Smooth Muscle Cell Cultures : Inhibition by Osteopontin Circ. Res., February 5, 1999; 84(2): 166 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Demer and Y. Tintut Osteopontin : Between a Rock and a Hard Plaque Circ. Res., February 5, 1999; 84(2): 250 - 252. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Scatena, M. Almeida, M. L. Chaisson, N. Fausto, R. F. Nicosia, and C. M. Giachelli NF-{kappa}B Mediates {alpha}v{beta}3 Integrin-induced Endothelial Cell Survival J. Cell Biol., May 18, 1998; 141(4): 1083 - 1093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tintut, F. Parhami, K. Bostrom, S. M. Jackson, and L. L. Demer cAMP Stimulates Osteoblast-like Differentiation of Calcifying Vascular Cells. POTENTIAL SIGNALING PATHWAY FOR VASCULAR CALCIFICATION J. Biol. Chem., March 27, 1998; 273(13): 7547 - 7553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang, C. Louden, T.-L. Yue, J. A. Ellison, F. C. Barone, H. A. Solleveld, and G. Z. Feuerstein Delayed Expression of Osteopontin after Focal Stroke in the Rat J. Neurosci., March 15, 1998; 18(6): 2075 - 2083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bayless, G. Meininger, J. Scholtz, and G. Davis Osteopontin is a ligand for the alpha4beta1 integrin J. Cell Sci., January 5, 1998; 111(9): 1165 - 1174. [Abstract] [PDF]
|
|
|
|
|
|
A. Hultgardh-Nilsson, C. Lovdahl, K. Blomgren, Bengt Kallin, and J. Thyberg Expression of phenotype- and proliferation-related genes in rat aortic smooth muscle cells in primary culture Cardiovasc Res, May 1, 1997; 34(2): 418 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Bennett, C. Chan, G. Vilaire, S. A. Mousa, and W. F. DeGrado Agonist-activated alpha vbeta 3 on Platelets and Lymphocytes Binds to the Matrix Protein Osteopontin J. Biol. Chem., March 28, 1997; 272(13): 8137 - 8140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Liaw, D. M. Lombardi, M. M. Almeida, S. M. Schwartz, D. deBlois, and C. M. Giachelli Neutralizing Antibodies Directed Against Osteopontin Inhibit Rat Carotid Neointimal Thickening After Endothelial Denudation Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 188 - 193. [Abstract] [Full Text]
|
|
|
|
|
|
D. deBlois, D. M. Lombardi, E. J. Su, A. W. Clowes, S. M. Schwartz, and C. M. Giachelli Angiotensin II Induction of Osteopontin Expression and DNA Replication in Rat Arteries Hypertension, December 1, 1996; 28(6): 1055 - 1063. [Abstract] [Full Text]
|
|
|
|
|
|
X. Wang, C. Louden, E. H. Ohlstein, J. M. Stadel, J.-L. Gu, and T.-L. Yue Osteopontin Expression in Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cells and Carotid Artery After Balloon Angioplasty Arterioscler Thromb Vasc Biol, November 1, 1996; 16(11): 1365 - 1372. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Guyton and K. F. Klemp Development of the Lipid-Rich Core in Human Atherosclerosis Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 4 - 11. [Full Text]
|
|
|
|
|
|
J.-H. Qiao, M. C. Fishbein, L. L. Demer, and A. J. Lusis Genetic Determination of Cartilaginous Metaplasia in Mouse Aorta Arterioscler Thromb Vasc Biol, December 1, 1995; 15(12): 2265 - 2272. [Abstract] [Full Text]
|
|
|
|
|
|
M. Hoshiga, C. E. Alpers, L. L. Smith, C. M. Giachelli, and S. M. Schwartz {alpha}vß3 Integrin Expression in Normal and Atherosclerotic Artery Circ. Res., December 1, 1995; 77(6): 1129 - 1135. [Abstract] [Full Text]
|
|
|
|
|
|
A. Shioi, Y. Nishizawa, S. Jono, H. Koyama, M. Hosoi, and H. Morii ß-Glycerophosphate Accelerates Calcification in Cultured Bovine Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 2003 - 2009. [Abstract] [Full Text]
|
|
|
|
|
|
C. M. Newman, B. C. Bruun, K. E. Porter, P. K. Mistry, C. M. Shanahan, and P. L. Weissberg Osteopontin Is Not a Marker for Proliferating Human Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 2010 - 2018. [Abstract] [Full Text]
|
|
|
|
|
|
L. Liaw, V. Lindner, S. M. Schwartz, A. F. Chambers, and C. M. Giachelli Osteopontin and ß3 Integrin Are Coordinately Expressed in Regenerating Endothelium In Vivo and Stimulate Arg-Gly-Asp–Dependent Endothelial Migration In Vitro Circ. Res., October 1, 1995; 77(4): 665 - 672. [Abstract] [Full Text]
|
|
|
|
|
|
H. Hao, S. Hirota, Y. Tsukamoto, M. Imakita, H. Ishibashi-Ueda, and C. Yutani Alterations of Bone Matrix Protein mRNA Expression in Rat Aorta In Vitro Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1474 - 1480. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Schwartz, D. deBlois, and E. R. M. O'Brien The Intima : Soil for Atherosclerosis and Restenosis Circ. Res., September 1, 1995; 77(3): 445 - 465. [Full Text]
|
|
|
|
|
|
E. B. Williams, I. Halpert, S. Wickline, G. Davison, W. C. Parks, and J. N. Rottman Osteopontin Expression Is Increased in the Heritable Cardiomyopathy of Syrian Hamsters Circulation, August 15, 1995; 92(4): 705 - 709. [Abstract] [Full Text]
|
|